[Use of beta-adrenergic blockers in neurologic and psychiatric clinical practice].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000437:Alcoholism / Q000188:drug therapy; D014151:Anti-Anxiety Agents; D002318:Cardiovascular Diseases / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D006980:Hyperthyroidism / Q000188:drug therapy; D001523:Mental Disorders / Q000188:drug therapy*; D008881:Migraine Disorders / Q000188:drug therapy; D009422:Nervous System Diseases / Q000188:drug therapy*; D010698:Phobic Disorders / Q000188:drug therapy; D011433:Propranolol / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000188:drug therapy; D014202:Tremor / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D011433:Propranolol
Primenenie beta-adrenoblokatorov v nevrologicheskoĭ i psikhiatricheskoĭ praktike.